Literature DB >> 3148995

Anti-Sm and anti-DNA antibodies in paired serum and synovial fluid samples from patients with SLE.

K M Pollard1, L J Furphy, J Webb.   

Abstract

Antibodies to nuclear antigens (ANAs) are frequently found in the serum of patients with connective tissue diseases (CTDs). Particularly systemic lupus erythematosus (SLE), and have been implicated in the immune-complex mediated pathogenesis of these diseases. In this study we have compared the occurrence of precipitating ANAs in paired samples of serum and synovial fluid from patients with different CTDs. Of the 30 patients examined 3 had precipitating ANAs in their serum only, 1 in the synovial fluid only, and 3 had antibodies in both serum and synovial fluid. Precipitating ANAs in synovial fluid were found in 3/6 patients with SLE, 1 patient with RA/Sjogren's syndrome overlap, and one patient with RA/SLE overlap. Of the other 15 patients with RA, 2 had precipitating antibodies only in their serum. Two of the SLE patients had anti-Sm antibody, one in serum only and the other in both serum and synovial fluid. Detection by ELISA of class specific anti-Sm antibodies in serum or synovial fluid paralleled the occurrence of antidenatured DNA antibodies when both specificities occurred together. One SLE patient did show evidence in synovial fluids of elevated concentrations of specific antibody classes to individual antigens; however, elevated levels were more frequently found in serum. Local production of ANAs does not, therefore, appear to be a feature of synovial fluids from SLE patients.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3148995     DOI: 10.1007/bf00269195

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  24 in total

1.  Antinuclear factors in synovial fluids.

Authors:  R N MacSween; T K Dalakos; M K Jasani; M E Wilson; J A Boyle; W W Buchanan; R B Goudie
Journal:  Lancet       Date:  1967-02-11       Impact factor: 79.321

2.  Determination of protein: a modification of the Lowry method that gives a linear photometric response.

Authors:  E F Hartree
Journal:  Anal Biochem       Date:  1972-08       Impact factor: 3.365

3.  Studies of immune deposits in synovial membranes and corresponding synovial fluids.

Authors:  K D Brandt; E S Cathcart; A S Cohen
Journal:  J Lab Clin Med       Date:  1968-10

4.  Antinuclear factors and chronic articular inflammation.

Authors:  N J Zvaifler; M M Martinez
Journal:  Clin Exp Immunol       Date:  1971-02       Impact factor: 4.330

Review 5.  Antibodies to DNA. A perspective.

Authors:  W Emlen; D S Pisetsky; R P Taylor
Journal:  Arthritis Rheum       Date:  1986-12

Review 6.  Autoantibodies to nuclear antigens (ANA): their immunobiology and medicine.

Authors:  E M Tan
Journal:  Adv Immunol       Date:  1982       Impact factor: 3.543

7.  LE cells in Reiter's syndrome.

Authors:  I W Tomlinson; M I Jayson
Journal:  Arthritis Rheum       Date:  1982-02

8.  Antinuclear antibodies and nuclear antigens in rheumatoid synovial fluids.

Authors:  P Robitaille; N J Zvaifler; E M Tan
Journal:  Clin Immunol Immunopathol       Date:  1973-04

9.  Systemic lupus erythematosus and DNA antibodies in pleural effusions.

Authors:  H Riska; F Fyhrquist; R K Selander; P E Hellström
Journal:  Scand J Rheumatol       Date:  1978       Impact factor: 3.641

10.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11
View more
  2 in total

1.  Correlation of anti-cytoskeleton antibody activities in synovial fluid with interleukin-6 in patients with osteoarthritis and inflammatory joint disease.

Authors:  W J Mayet; E Hermann; M Bachmann; M Manns; K H Meyer zum Büschenfelde
Journal:  Klin Wochenschr       Date:  1990-07-05

2.  Salivary anti-nuclear antibody (ANA) mirrors serum ANA in systemic lupus erythematosus.

Authors:  Ting Zhang; Yong Du; Qingqing Wu; Hao Li; Thao Nguyen; Gabriel Gidley; Valeria Duran; Daniel Goldman; Michelle Petri; Chandra Mohan
Journal:  Arthritis Res Ther       Date:  2022-01-03       Impact factor: 5.156

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.